HRP20110534T1 - Novi spojevi i njihova uporaba - Google Patents

Novi spojevi i njihova uporaba Download PDF

Info

Publication number
HRP20110534T1
HRP20110534T1 HR20110534T HRP20110534T HRP20110534T1 HR P20110534 T1 HRP20110534 T1 HR P20110534T1 HR 20110534 T HR20110534 T HR 20110534T HR P20110534 T HRP20110534 T HR P20110534T HR P20110534 T1 HRP20110534 T1 HR P20110534T1
Authority
HR
Croatia
Prior art keywords
compound according
compound
pharmaceutical composition
formula
alkyl
Prior art date
Application number
HR20110534T
Other languages
English (en)
Croatian (hr)
Inventor
Homman Mohammed
Engqvist Robert
S�derberg-Naucl�r Cecilia
Bergman Jan
Original Assignee
Vironova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vironova Ab filed Critical Vironova Ab
Publication of HRP20110534T1 publication Critical patent/HRP20110534T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20110534T 2006-01-23 2007-01-22 Novi spojevi i njihova uporaba HRP20110534T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0600134A SE529777C2 (sv) 2006-01-23 2006-01-23 Nya föreningar och användning därav
PCT/SE2007/050033 WO2007084073A1 (fr) 2006-01-23 2007-01-22 Nouveaux composés et applications

Publications (1)

Publication Number Publication Date
HRP20110534T1 true HRP20110534T1 (hr) 2011-09-30

Family

ID=38287919

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110534T HRP20110534T1 (hr) 2006-01-23 2007-01-22 Novi spojevi i njihova uporaba

Country Status (24)

Country Link
US (1) US8076341B2 (fr)
EP (1) EP1976853B1 (fr)
JP (1) JP5190379B2 (fr)
CN (1) CN101374845B (fr)
AR (1) AR059149A1 (fr)
AT (1) ATE506365T1 (fr)
AU (1) AU2007206092B2 (fr)
BR (1) BRPI0707203C1 (fr)
CA (1) CA2637417C (fr)
CY (1) CY1112596T1 (fr)
DE (1) DE602007014008D1 (fr)
DK (1) DK1976853T3 (fr)
ES (1) ES2365423T3 (fr)
HR (1) HRP20110534T1 (fr)
IL (1) IL192820A (fr)
NZ (1) NZ569840A (fr)
PL (1) PL1976853T3 (fr)
PT (1) PT1976853E (fr)
RS (1) RS51933B (fr)
RU (1) RU2437887C2 (fr)
SE (1) SE529777C2 (fr)
SI (1) SI1976853T1 (fr)
WO (1) WO2007084073A1 (fr)
ZA (1) ZA200806315B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
EP2489354A1 (fr) 2011-02-18 2012-08-22 Vironova AB Formulation pharmaceutique de B220 pour le traitement topique de l'herpès
CN105061432B (zh) * 2015-07-16 2017-09-29 河北大学 6H‑吲哚[2,3‑b]喹喔啉衍生物、药物组合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600261D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Indolokinoxaliner med substituenter i 6-position som innehaller cykliska grupper
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner
SE504862C2 (sv) * 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
SE527639C2 (sv) * 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner

Also Published As

Publication number Publication date
ATE506365T1 (de) 2011-05-15
SE0600134L (sv) 2007-07-24
JP5190379B2 (ja) 2013-04-24
RU2008134509A (ru) 2010-02-27
DE602007014008D1 (de) 2011-06-01
PL1976853T3 (pl) 2011-09-30
AR059149A1 (es) 2008-03-12
US20090318458A1 (en) 2009-12-24
CN101374845A (zh) 2009-02-25
EP1976853A4 (fr) 2010-04-21
BRPI0707203A2 (pt) 2011-04-26
US8076341B2 (en) 2011-12-13
CN101374845B (zh) 2012-07-18
ES2365423T3 (es) 2011-10-04
RS51933B (sr) 2012-02-29
PT1976853E (pt) 2011-07-20
IL192820A0 (en) 2009-02-11
BRPI0707203B1 (pt) 2020-11-10
CA2637417A1 (fr) 2007-07-26
BRPI0707203C1 (pt) 2021-05-25
AU2007206092B2 (en) 2012-05-17
EP1976853A1 (fr) 2008-10-08
CY1112596T1 (el) 2016-02-10
NZ569840A (en) 2011-06-30
WO2007084073A1 (fr) 2007-07-26
DK1976853T3 (da) 2011-08-08
IL192820A (en) 2012-08-30
JP2009523792A (ja) 2009-06-25
CA2637417C (fr) 2014-08-05
EP1976853B1 (fr) 2011-04-20
ZA200806315B (en) 2010-04-28
AU2007206092A1 (en) 2007-07-26
SI1976853T1 (sl) 2011-09-30
SE529777C2 (sv) 2007-11-20
BRPI0707203B8 (pt) 2020-12-08
RU2437887C2 (ru) 2011-12-27

Similar Documents

Publication Publication Date Title
HRP20230281T1 (hr) Postupak sinteze
ES2228557T3 (es) Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa.
JP6987859B2 (ja) Ｍａｇｌ阻害剤
JP2009534302A5 (fr)
HRP20160500T1 (hr) Nitrooksi-derivati prostaglandina
JP2005524621A5 (fr)
JP6621329B2 (ja) 新規化合物、それらの合成及びそれらの使用
JPH06157472A (ja) ジフェニルオキサゾール、チアゾールおよびイミダゾールのアデノシン再吸収阻害誘導体
ES2228555T3 (es) Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa.
HRP20170695T1 (hr) Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanoni i njihova uporaba u obliku lijeka
CN105849108A (zh) 磷脂酰肌醇3-激酶抑制剂的制备方法
YU48865B (sh) Postupak prema kome se, bez izdvajanja međuproizvoda, pripremaju derivati 3-hinolon-karbonske kiseline
HRP20110534T1 (hr) Novi spojevi i njihova uporaba
AU2013215549B2 (en) Novel morpholinyl derivatives useful as MOGAT-2 inhibitors
KR20190134722A (ko) 치료 화합물 및 방법
DE602004017894D1 (de) Biphenylderivate, die sich als rar-rezeptor-aktivierende liganden eignen, verfahren zu deren herstellung und deren verwendung in der humanmedizin und in kosmetika
ES2614997T3 (es) Compuestos reguladores del crecimiento vegetal
JP5315336B2 (ja) 精神疾患治療用の新規化合物とその調剤及び使用
WO2017134617A1 (fr) Procédé de préparation de dasatinib amorphe
KR100896667B1 (ko) 신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물
SI1831186T1 (sl) Postopek za sintezo valsartana
WO2011065420A1 (fr) Procédé de fabrication d'un dérivé de 1-méthyl-1h-benzimidazole substitué en 6 et intermédiaire de fabrication issu de ce procédé
WO2004087716A1 (fr) Dimeres de pyrrolo(2,1-c) (1,4) benzodiazepine en tant qu'agents antitumoraux et procede correspondant
CA2465272A1 (fr) Separation de regio-isomeres de phthalocyanines metalliques
CN102351728A (zh) 一种油酰乙醇胺及其衍生物的合成方法